Enanta Pharmaceuticals shares owned by Farallon Capital Management
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Farallon Capital Management
from 13F filings
Historical chart of Farallon Capital Management investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Enanta Pharmaceuticals by Farallon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25M | 2.1M | 11.97 |
| 2025-06-30 | $16M | 2.1M | 7.56 |
| 2025-03-31 | $12M | 2.1M | 5.52 |
| 2024-12-31 | $12M | 2.1M | 5.75 |
| 2024-09-30 | $22M | 2.1M | 10.36 |
| 2024-06-30 | $27M | 2.1M | 12.97 |
| 2024-03-31 | $37M | 2.1M | 17.46 |
| 2023-09-30 | $21M | 1.9M | 11.17 |
| 2023-06-30 | $40M | 1.9M | 21.40 |
| 2023-03-31 | $63M | 1.6M | 40.44 |
| 2022-12-31 | $72M | 1.6M | 46.52 |
| 2022-09-30 | $80M | 1.6M | 51.87 |
| 2022-06-30 | $73M | 1.6M | 47.27 |
| 2022-03-31 | $110M | 1.6M | 71.18 |
| 2021-12-31 | $118M | 1.6M | 74.78 |
| 2021-09-30 | $113M | 2.0M | 56.81 |
| 2021-06-30 | $88M | 2.0M | 44.01 |
| 2021-03-31 | $98M | 2.0M | 49.32 |
| 2020-12-31 | $75M | 1.8M | 42.10 |
| 2020-09-30 | $81M | 1.8M | 45.78 |
| 2020-06-30 | $88M | 1.8M | 50.21 |
| 2020-03-31 | $90M | 1.8M | 51.43 |
| 2019-12-31 | $108M | 1.8M | 61.78 |
| 2019-09-30 | $77M | 1.3M | 60.08 |
| 2019-06-30 | $81M | 960k | 84.38 |
| 2019-03-31 | $90M | 940k | 95.52 |
| 2018-12-31 | $66M | 925k | 70.83 |
| 2018-09-30 | $74M | 868k | 85.46 |
| 2018-06-30 | $125M | 1.1M | 115.90 |
| 2018-03-31 | $74M | 915k | 80.91 |
| 2017-12-31 | $54M | 925k | 58.68 |
| 2017-09-30 | $19M | 412k | 46.80 |
More positions owned by Farallon Capital Management
View all positions for Farallon Capital Management